Menotropin - IBSA

Drug Profile

Menotropin - IBSA

Alternative Names: Merional

Latest Information Update: 10 Jan 2017

Price : $50

At a glance

  • Originator IBSA
  • Class Infertility therapies; Menotropins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Female infertility; Male infertility; Polycystic ovary syndrome

Most Recent Events

  • 10 Nov 2016 Launched for Female infertility in Poland (SC,IM)
  • 03 Nov 2016 Launched for Female infertility in Czech Republic (IM,SC)
  • 03 Nov 2016 Launched for Male infertility in Czech Republic (SC,IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top